Evolution of Systemic Sclerosis–Associated Interstitial Lung Disease One Year After Hematopoietic Stem Cell Transplantation or Cyclophosphamide

OBJECTIVE: Hematopoietic stem cell transplantation (HSCT) and cyclophosphamide (CYC) are treatment options for progressive systemic sclerosis associated with interstitial lung disease (SSc‐ILD). The aims of our retrospective observational study were to evaluate: 1) the evolution of SSc‐ILD in SSc pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Ciaffi, Jacopo, van Leeuwen, Nina M., Boonstra, Maaike, Kroft, Lucia J. M., Schouffoer, Anne A., Ninaber, Maarten K., Huizinga, Tom W. J., de Vries‐Bouwstra, Jeska K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2022
Materias:
Systemic Sclerosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303567/
https://www.ncbi.nlm.nih.gov/pubmed/32961038
http://dx.doi.org/10.1002/acr.24451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303567/
https://www.ncbi.nlm.nih.gov/pubmed/32961038
http://dx.doi.org/10.1002/acr.24451

Ejemplares similares